Related Experiment Video
Updated: Aug 8, 2026

03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Diagnostic thresholds in thyroid cytopathology: toward biological risk stratification
Sayaka Tanaka1, Tomoko Wakasa2, Kennichi Kakudo3
1Department of Legal Medicine, Osaka University Faculty of Medicine/Graduate School of Medicine, Suita, Osaka, Japan.
Journal of the American Society of Cytopathology
|July 23, 2026
Summary
Thyroid cytology is shifting from a binary benign/malignant classification to a biologic risk stratification. This approach better manages thyroid neoplasms by considering tumor behavior for tailored clinical decisions.
Area of Science:
- Pathology
- Oncology
- Cytopathology
Background:
- Traditional thyroid cytopathology uses a binary benign/malignant framework.
- This paradigm is challenged by borderline neoplasms, indolent carcinomas, and heterogeneous tumors.
- A biologically informed approach is needed for accurate thyroid cancer diagnosis.
Purpose of the Study:
- To review conceptual developments in thyroid cytopathology.
- To emphasize limitations of the binary paradigm and introduce diagnostic threshold theory.
- To highlight the shift towards biologic risk stratification in thyroid cytology.
Main Methods:
- Review of conceptual developments in thyroid cytopathology.
- Analysis of diagnostic threshold theory's impact.
- Integration of cytomorphology with ultrasound, molecular testing, and clinical factors.
Main Results:
- Diagnostic thresholds influence cytologic category distribution, resection rates, and malignancy risk.
- Thyroid cytology serves as biologic risk stratification, not a definitive malignancy diagnosis.
- Cytologic findings differentiate indolent from aggressive tumors.
Conclusions:
- A biology-based approach aligns interpretation with tumor behavior.
- Proportional clinical management, including active surveillance, is supported.
- Integrated risk stratification enhances patient care for thyroid neoplasms.
